First CE-IVD marked AI solution for prognostic risk stratification of breast cancer patients
1 June 2022
Stratipath, a global leader in AI-based precision diagnostic solutions, today
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Stratipath, a global leader in AI-based precision diagnostic solutions, today
Vinnova grants SEK 20 million to the Swedish AI Precision
A published high-impact scientific article from Karolinska Institutet shows that
Abstract: We compared estrogen receptor (ER), progesterone receptor (PR), human
Stratipath is featured in NyTeknik, Sweden’s largest technology news magazine.
Read the article